首页 > 最新文献

Journal of Medical Imaging and Radiation Oncology最新文献

英文 中文
Pathology and risk stratification-based evaluation of ovarian masses on MRI. 卵巢肿块MRI病理及风险分层评价。
IF 2.2 4区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-12-27 DOI: 10.1111/1754-9485.13819
Ayesha Arora, Clair Shadbolt, Kim Lam, Sarita Bahure, Yu Xuan Kitzing

Characterisation of an indeterminate ovarian mass is important as it guides management and clinical outcomes. Ultrasound is the first-line modality in the assessment of ovarian tumours. When ovarian masses are indeterminate on ultrasound, MRI provides excellent resolution in tissue characterisation and enhancement patterns. Ovarian masses can be categorised based on risk-scoring systems such as the American College of Radiology (ACR) MRI Ovarian-Adnexal Reporting and Data System (O-RADS). The imaging features of non-neoplastic, benign, borderline and malignant neoplastic ovarian lesions are discussed in this review with a focus on the pathology process accounting for the MRI appearance. Characteristic findings and clues in differentiating a benign lesion from a malignancy are presented in this review.

不确定卵巢肿块的特征是重要的,因为它指导管理和临床结果。超声是评估卵巢肿瘤的一线方法。当卵巢肿块在超声上不确定时,MRI在组织特征和增强模式上提供了很好的分辨率。卵巢肿块可以根据风险评分系统进行分类,如美国放射学会(ACR) MRI卵巢附件报告和数据系统(O-RADS)。本文讨论了卵巢非肿瘤性、良性、交界性和恶性肿瘤病变的影像学特征,重点讨论了其MRI表现的病理过程。特征性的发现和线索,以区分良性病变和恶性肿瘤提出了在这篇综述。
{"title":"Pathology and risk stratification-based evaluation of ovarian masses on MRI.","authors":"Ayesha Arora, Clair Shadbolt, Kim Lam, Sarita Bahure, Yu Xuan Kitzing","doi":"10.1111/1754-9485.13819","DOIUrl":"https://doi.org/10.1111/1754-9485.13819","url":null,"abstract":"<p><p>Characterisation of an indeterminate ovarian mass is important as it guides management and clinical outcomes. Ultrasound is the first-line modality in the assessment of ovarian tumours. When ovarian masses are indeterminate on ultrasound, MRI provides excellent resolution in tissue characterisation and enhancement patterns. Ovarian masses can be categorised based on risk-scoring systems such as the American College of Radiology (ACR) MRI Ovarian-Adnexal Reporting and Data System (O-RADS). The imaging features of non-neoplastic, benign, borderline and malignant neoplastic ovarian lesions are discussed in this review with a focus on the pathology process accounting for the MRI appearance. Characteristic findings and clues in differentiating a benign lesion from a malignancy are presented in this review.</p>","PeriodicalId":16218,"journal":{"name":"Journal of Medical Imaging and Radiation Oncology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142895347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IRSA ASM 2024 Abstract 摘要。
IF 2.2 4区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-12-19 DOI: 10.1111/1754-9485.13764

Aim: Interventionalist experience high-lifetime radiation dosages due to the use of pulsed fluoroscopy. They also experience orthopaedic problems due to the necessity of wearing lead gowns to protect from this radiation. To alleviate both the radiation and orthopaedic issues, we trialled an innovative shielding system, Rampart (tm) which surrounds the patient's torso with lead equivalent acrylic shielding. Our trial period coincided with the initial COVID-19 outbreak and lockdowns which provided an additional use of the shielding as a protection from spread of COVID-19 infection from patients.

Method: Using Ray safe (tm) i3 Dosimeters, we measured primary operator radiation dosimetry. This was measured at the head (H), upper torso (T) and waist height (W). Both with the Rampart (tm) shield and without it. The measurements were conducted over a usual week's case load.

Results: 20 cases were performed, 10 with the Rampart (tm) system in place and 10 without. At the primary operator position we found an effective radiation attenuation of H: 70.3%, T: 98.3%, W: 99.5% with lead gowns. Compared to an effective radiation attenuation just using the Rampart(tm) external shielding of H: 89.3%, T: 92.4%, W: 89.0%. Using both lead gowns and the Rampart (tm) gave over 99.9 %. Airflow test also showed a laminar air flow away from the operator from the patient's head.

Conclusion: Whilst not as effective alone as lead gowns in radiation attenuation, the Rampart (tm) system was demonstrated to be an effective radiation safety device with the possibility of no lead or lighter lead use. Additional benefits that were observed from its use included significant radiation protection to the operator, protection to body areas not protected by lead, (head arms) as well shielding from direct aerosol contact with the patient which has proven to be an important consideration in the current COVID-19 pandemic.

{"title":"IRSA ASM 2024 Abstract","authors":"","doi":"10.1111/1754-9485.13764","DOIUrl":"10.1111/1754-9485.13764","url":null,"abstract":"<p><b>Aim:</b> Interventionalist experience high-lifetime radiation dosages due to the use of pulsed fluoroscopy. They also experience orthopaedic problems due to the necessity of wearing lead gowns to protect from this radiation. To alleviate both the radiation and orthopaedic issues, we trialled an innovative shielding system, Rampart (tm) which surrounds the patient's torso with lead equivalent acrylic shielding. Our trial period coincided with the initial COVID-19 outbreak and lockdowns which provided an additional use of the shielding as a protection from spread of COVID-19 infection from patients.</p><p><b>Method:</b> Using Ray safe (tm) i3 Dosimeters, we measured primary operator radiation dosimetry. This was measured at the head (H), upper torso (T) and waist height (W). Both with the Rampart (tm) shield and without it. The measurements were conducted over a usual week's case load.</p><p><b>Results:</b> 20 cases were performed, 10 with the Rampart (tm) system in place and 10 without. At the primary operator position we found an effective radiation attenuation of H: 70.3%, T: 98.3%, W: 99.5% with lead gowns. Compared to an effective radiation attenuation just using the Rampart(tm) external shielding of H: 89.3%, T: 92.4%, W: 89.0%. Using both lead gowns and the Rampart (tm) gave over 99.9 %. Airflow test also showed a laminar air flow away from the operator from the patient's head.</p><p><b>Conclusion:</b> Whilst not as effective alone as lead gowns in radiation attenuation, the Rampart (tm) system was demonstrated to be an effective radiation safety device with the possibility of no lead or lighter lead use. Additional benefits that were observed from its use included significant radiation protection to the operator, protection to body areas not protected by lead, (head arms) as well shielding from direct aerosol contact with the patient which has proven to be an important consideration in the current COVID-19 pandemic.</p>","PeriodicalId":16218,"journal":{"name":"Journal of Medical Imaging and Radiation Oncology","volume":"68 8","pages":"e4"},"PeriodicalIF":2.2,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1754-9485.13764","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142854518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IRSA ASM 2024 Abstract 摘要。
IF 2.2 4区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-12-19 DOI: 10.1111/1754-9485.13763

Aim: Radiological interventions are increasingly complex and also increasingly performed on high body mass index (BMI) patients. As such we sought to quantify the radiation dose to the eyes of the operator, the dose area product and skin dose to the patient, as well as variations in cardiac angiographic image quality. Over the range of normal to high BMI's.

Methods: Five thickness of Acrylic 15, 20, 25, 30 and 35 cm were used to simulate increasing patient BMI. The patient dose area product and skin dose were measured from the built-in metering systems of the angiographic system. The simulated operator eye dose was measured using (Rando) tm Phantom and a (Unfors)tm radiation detector at 150–170 cm in 5 cm gradients at the primary operator position. For image quality measurement, a Westmead testing object was used to test high and low contrast range and line pairs per 0.5 mm.

Results: Our study shows that whilst a low-grade linear decrease in image quality and corresponding rise in radiation dose is seen over the standard patient BMI ranges. There is a very large nonlinear drop in image quality and corresponding large rise in radiation dose in the high BMI patient range (over 25) using standard settings. Our secondary aim was proven in the results showing the high effectiveness (over 90%) of the standard lead equivalent acrylic shielding in protecting the operators' eyes. Especially for the very high levels found in the extreme patient size cohort.

Conclusion: These results indicate the important need of the radiographers' role in radiation safety. Selecting the most efficient frame rate/Ma settings possible, positioning of the detector, monitoring of ongoing case dose and that operators are using radiation protection equipment, especially the ceiling acrylic (Pb) shield for the higher BMI patients.

{"title":"IRSA ASM 2024 Abstract","authors":"","doi":"10.1111/1754-9485.13763","DOIUrl":"10.1111/1754-9485.13763","url":null,"abstract":"<p><b>Aim:</b> Radiological interventions are increasingly complex and also increasingly performed on high body mass index (BMI) patients. As such we sought to quantify the radiation dose to the eyes of the operator, the dose area product and skin dose to the patient, as well as variations in cardiac angiographic image quality. Over the range of normal to high BMI's.</p><p><b>Methods:</b> Five thickness of Acrylic 15, 20, 25, 30 and 35 cm were used to simulate increasing patient BMI. The patient dose area product and skin dose were measured from the built-in metering systems of the angiographic system. The simulated operator eye dose was measured using (Rando) tm Phantom and a (Unfors)tm radiation detector at 150–170 cm in 5 cm gradients at the primary operator position. For image quality measurement, a Westmead testing object was used to test high and low contrast range and line pairs per 0.5 mm.</p><p><b>Results:</b> Our study shows that whilst a low-grade linear decrease in image quality and corresponding rise in radiation dose is seen over the standard patient BMI ranges. There is a very large nonlinear drop in image quality and corresponding large rise in radiation dose in the high BMI patient range (over 25) using standard settings. Our secondary aim was proven in the results showing the high effectiveness (over 90%) of the standard lead equivalent acrylic shielding in protecting the operators' eyes. Especially for the very high levels found in the extreme patient size cohort.</p><p><b>Conclusion:</b> These results indicate the important need of the radiographers' role in radiation safety. Selecting the most efficient frame rate/Ma settings possible, positioning of the detector, monitoring of ongoing case dose and that operators are using radiation protection equipment, especially the ceiling acrylic (Pb) shield for the higher BMI patients.</p>","PeriodicalId":16218,"journal":{"name":"Journal of Medical Imaging and Radiation Oncology","volume":"68 8","pages":"e3"},"PeriodicalIF":2.2,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1754-9485.13763","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142854469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The ELVIS study: Medium and long-term Efficacy of LVIS EVO stent-assisted coil embolisation for unruptured saccular intracranial aneurysms-A tertiary single-centre experience. ELVIS研究:LVIS EVO支架辅助线圈栓塞治疗未破裂的囊状颅内动脉瘤的中期和长期疗效-三级单中心经验。
IF 2.2 4区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-12-12 DOI: 10.1111/1754-9485.13820
Krishna Pranathi Settipalli, Sophie Dunkerton, John Hilton, Grace Aw, Gregory Lock, Kenneth Mitchell, Alan Coulthard

Introduction: The LVIS EVO (MicroVention®) is a braided stent designed to assist coil embolisation of intracranial aneurysms. It offers several structural innovations over previous and currently available braided, and laser-cut, stents that are theorised to improve procedural success. This retrospective audit aims to determine the success and complication rates of LVIS EVO-assisted coil embolisation in unruptured saccular aneurysms at a tertiary neurovascular referral centre in Queensland, Australia.

Methods: The medical records of all patients who underwent elective LVIS EVO-assisted coil embolisation at our institution between 2020 and 2024 were reviewed. Clinical and radiologic outcomes, including occlusion rate, occlusion grade (modified Raymond Roy classification-MRRC), complications, recurrence rate, and change in modified Rankin scale (mRS) were recorded, alongside aneurysm characteristics and technical procedural details.

Results: Of 29 cases, 2 were excluded due to complex aneurysms requiring off-label LVIS EVO use. Twenty-seven (27) saccular aneurysms in 26 patients (18 female; 8 male) were included. Most (22/27) involved the anterior cerebral artery (ACA), primarily the anterior communicating artery (18/27). Complete occlusion was seen in 55.6% (15/27) of cases immediately post-procedure, in 85.2% (23/27) at 3 months, and in 84.2% (16/19) at a median of 12-months post-procedure. A recurrence was seen in 7.4% (2/27) of patients. No procedural or long-term complications, and no significant changes in 90-day mRS, were noted.

Conclusion: Our results show 100% technical success reflecting existing literature and contribute further by providing data on medium to long-term success rates with LVIS EVO-assisted coil embolisation for unruptured saccular aneurysms.

简介:LVIS EVO (MicroVention®) 是一种编织支架,设计用于辅助颅内动脉瘤的线圈栓塞。与以前和目前可用的编织支架和激光切割支架相比,它在结构上进行了多项创新,理论上可提高手术成功率。这项回顾性审计旨在确定澳大利亚昆士兰州一家三级神经血管转诊中心在 LVIS EVO 辅助线圈栓塞治疗未破裂囊状动脉瘤的成功率和并发症发生率:方法:回顾了2020年至2024年期间在本院接受选择性LVIS EVO辅助线圈栓塞术的所有患者的病历。记录了临床和放射学结果,包括闭塞率、闭塞等级(改良雷蒙德-罗伊分级-MRRC)、并发症、复发率和改良兰金量表(mRS)的变化,以及动脉瘤特征和手术技术细节:结果:在29个病例中,有2个因复杂动脉瘤需要标签外使用LVIS EVO而被排除在外。共纳入26名患者(18名女性;8名男性)的27个囊状动脉瘤。大多数(22/27)涉及大脑前动脉(ACA),主要是前交通动脉(18/27)。55.6%的病例(15/27)在术后立即完全闭塞,85.2%的病例(23/27)在术后3个月完全闭塞,84.2%的病例(16/19)在术后12个月完全闭塞。7.4%(2/27)的患者复发。没有发现手术或长期并发症,90天的mRS也没有明显变化:我们的研究结果显示技术成功率为100%,反映了现有文献的研究结果,并提供了LVIS EVO辅助线圈栓塞治疗未破裂囊状动脉瘤的中长期成功率数据,为研究做出了进一步贡献。
{"title":"The ELVIS study: Medium and long-term Efficacy of LVIS EVO stent-assisted coil embolisation for unruptured saccular intracranial aneurysms-A tertiary single-centre experience.","authors":"Krishna Pranathi Settipalli, Sophie Dunkerton, John Hilton, Grace Aw, Gregory Lock, Kenneth Mitchell, Alan Coulthard","doi":"10.1111/1754-9485.13820","DOIUrl":"https://doi.org/10.1111/1754-9485.13820","url":null,"abstract":"<p><strong>Introduction: </strong>The LVIS EVO (MicroVention<sup>®</sup>) is a braided stent designed to assist coil embolisation of intracranial aneurysms. It offers several structural innovations over previous and currently available braided, and laser-cut, stents that are theorised to improve procedural success. This retrospective audit aims to determine the success and complication rates of LVIS EVO-assisted coil embolisation in unruptured saccular aneurysms at a tertiary neurovascular referral centre in Queensland, Australia.</p><p><strong>Methods: </strong>The medical records of all patients who underwent elective LVIS EVO-assisted coil embolisation at our institution between 2020 and 2024 were reviewed. Clinical and radiologic outcomes, including occlusion rate, occlusion grade (modified Raymond Roy classification-MRRC), complications, recurrence rate, and change in modified Rankin scale (mRS) were recorded, alongside aneurysm characteristics and technical procedural details.</p><p><strong>Results: </strong>Of 29 cases, 2 were excluded due to complex aneurysms requiring off-label LVIS EVO use. Twenty-seven (27) saccular aneurysms in 26 patients (18 female; 8 male) were included. Most (22/27) involved the anterior cerebral artery (ACA), primarily the anterior communicating artery (18/27). Complete occlusion was seen in 55.6% (15/27) of cases immediately post-procedure, in 85.2% (23/27) at 3 months, and in 84.2% (16/19) at a median of 12-months post-procedure. A recurrence was seen in 7.4% (2/27) of patients. No procedural or long-term complications, and no significant changes in 90-day mRS, were noted.</p><p><strong>Conclusion: </strong>Our results show 100% technical success reflecting existing literature and contribute further by providing data on medium to long-term success rates with LVIS EVO-assisted coil embolisation for unruptured saccular aneurysms.</p>","PeriodicalId":16218,"journal":{"name":"Journal of Medical Imaging and Radiation Oncology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142818342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lung cancer screening in Australia: The time approaches. 澳大利亚的肺癌筛查:时间越来越近。
IF 2.2 4区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-12-12 DOI: 10.1111/1754-9485.13818
Miranda Siemienowicz
{"title":"Lung cancer screening in Australia: The time approaches.","authors":"Miranda Siemienowicz","doi":"10.1111/1754-9485.13818","DOIUrl":"https://doi.org/10.1111/1754-9485.13818","url":null,"abstract":"","PeriodicalId":16218,"journal":{"name":"Journal of Medical Imaging and Radiation Oncology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142818341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of plan quality, safety, and toxicity of brachytherapy for locally advanced cervical cancer in an Australian setting following changes in prescription and applicator design. 在处方和涂抹器设计改变后,澳大利亚近距离治疗局部晚期宫颈癌的计划质量、安全性和毒性评估
IF 2.2 4区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-12-12 DOI: 10.1111/1754-9485.13811
Emily Flower, Gemma Busuttil, Eireann Cosgriff, Niluja Thiruthaneeswaran, Salman Zanjani, Emma Sullivan, Alison Salkeld, Jonathan Sykes, David Thwaites, Jennifer Chard

Introduction: Chemoradiotherapy with MRI-guided brachytherapy boosts is the standard of care for locally advanced cervical cancer. Data from the RetroEMBRACE and EMBRACE I trials provide dose-response curves for target volumes and OAR. This study evaluated plan quality, safety and toxicity following escalation of the CTV_HR D90 prescription from 80-90 Gy to 85-95 Gy for two different applicator designs.

Methods: A retrospective dosimetric plan quality review was undertaken for consecutively treated locally advanced cervical cancer brachytherapy boosts between 2017 and 2022, and the relationships between implant total reference air kerma (TRAK), CTV_HR volume and vaginal dose were investigated. Safety and ≤grade 3 toxicity results were evaluated.

Results: Seventy patients were identified. All patients received a CTV_HR D90 dose >85 Gy and rectum D2cm3 of <75 Gy, while 88.6% of patients received a bladder D2cm3 <90 Gy. Needles were used in 48.6% of patients, and the mean percentage needle TRAK was 38.2%. Increasing the percentage of needle TRAK decreased vaginal TRAK. Sixty-three patients had more than 12 months of follow-up (median 27 months). From this cohort, grade 3 or higher toxicity for vaginal, genitourinary, gastrointestinal and fistula events were seen in 3.2%, 1.6%, 0% and 3.2% of patients, respectively.

Conclusion: Increased dose prescriptions and a change of applicator design were successfully adopted into an Australian practice. Applicator design and interstitial needle use affect the plan quality and ability to meet OAR dose constraints following target dose escalation. No safety concerns with needle use or dose escalation were identified.

导读:mri引导下的近距离放化疗是局部晚期宫颈癌的标准治疗方法。RetroEMBRACE和EMBRACE I试验的数据提供了靶体积和OAR的剂量-反应曲线。本研究评估了两种不同涂抹器设计下CTV_HR D90处方从80-90 Gy增加到85-95 Gy后的计划质量、安全性和毒性。方法:回顾性评价2017 - 2022年连续治疗的局部晚期宫颈癌近距离放疗的剂量学计划质量,探讨植入物总参考空气体积(TRAK)、CTV_HR体积与阴道剂量的关系。对安全性和≤3级毒性结果进行了评估。结果:共发现70例患者。所有患者接受CTV_HR D90剂量>85 Gy,直肠D2cm3 3结论:增加剂量处方和改变涂药器设计成功地应用于澳大利亚的实践。施药器的设计和间隙针的使用影响计划的质量和在目标剂量增加后满足OAR剂量限制的能力。没有发现针头使用或剂量增加的安全问题。
{"title":"Evaluation of plan quality, safety, and toxicity of brachytherapy for locally advanced cervical cancer in an Australian setting following changes in prescription and applicator design.","authors":"Emily Flower, Gemma Busuttil, Eireann Cosgriff, Niluja Thiruthaneeswaran, Salman Zanjani, Emma Sullivan, Alison Salkeld, Jonathan Sykes, David Thwaites, Jennifer Chard","doi":"10.1111/1754-9485.13811","DOIUrl":"https://doi.org/10.1111/1754-9485.13811","url":null,"abstract":"<p><strong>Introduction: </strong>Chemoradiotherapy with MRI-guided brachytherapy boosts is the standard of care for locally advanced cervical cancer. Data from the RetroEMBRACE and EMBRACE I trials provide dose-response curves for target volumes and OAR. This study evaluated plan quality, safety and toxicity following escalation of the CTV_HR D90 prescription from 80-90 Gy to 85-95 Gy for two different applicator designs.</p><p><strong>Methods: </strong>A retrospective dosimetric plan quality review was undertaken for consecutively treated locally advanced cervical cancer brachytherapy boosts between 2017 and 2022, and the relationships between implant total reference air kerma (TRAK), CTV_HR volume and vaginal dose were investigated. Safety and ≤grade 3 toxicity results were evaluated.</p><p><strong>Results: </strong>Seventy patients were identified. All patients received a CTV_HR D90 dose >85 Gy and rectum D2cm<sup>3</sup> of <75 Gy, while 88.6% of patients received a bladder D2cm<sup>3</sup> <90 Gy. Needles were used in 48.6% of patients, and the mean percentage needle TRAK was 38.2%. Increasing the percentage of needle TRAK decreased vaginal TRAK. Sixty-three patients had more than 12 months of follow-up (median 27 months). From this cohort, grade 3 or higher toxicity for vaginal, genitourinary, gastrointestinal and fistula events were seen in 3.2%, 1.6%, 0% and 3.2% of patients, respectively.</p><p><strong>Conclusion: </strong>Increased dose prescriptions and a change of applicator design were successfully adopted into an Australian practice. Applicator design and interstitial needle use affect the plan quality and ability to meet OAR dose constraints following target dose escalation. No safety concerns with needle use or dose escalation were identified.</p>","PeriodicalId":16218,"journal":{"name":"Journal of Medical Imaging and Radiation Oncology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142818340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characterising high-risk plaque on cardiac CT. 心脏CT高危斑块的特征分析。
IF 2.2 4区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-12-12 DOI: 10.1111/1754-9485.13817
Abdul Rahman Ihdayhid, Amro Sehly, Nick S R Lan, Nadia Denston, Benjamin J W Chow, David E Newby, Michelle C Williams, Girish Dwivedi

Coronary computed tomography angiography (CCTA) is a well-established and reliable non-invasive imaging modality that provides a comprehensive assessment of coronary artery anatomy and luminal stenosis due to atherosclerosis. Owing to advances in CCTA software and technology, the composition and morphology of coronary plaque can be accurately evaluated. Adverse features which identify plaque as being high-risk or 'vulnerable' can provide a personalised cardiovascular risk assessment over and above stenosis severity. High-risk plaque features on CCTA include spotty calcification, low attenuation plaque, positive remodelling and the napkin ring sign. However, it can be challenging to characterise high-risk plaque accurately on CCTA, and as such, education and experience are required. In this pictorial essay, a comprehensive visual guide to high-risk plaque features on CCTA is provided, with clear examples and challenging cases that highlight common pitfalls. It is important for expert readers to properly identify these features given their association with adverse outcomes and potential future implications on intensive goal-directed medical therapy.

冠状动脉计算机断层血管造影(CCTA)是一种完善可靠的无创成像方式,可全面评估冠状动脉解剖和动脉粥样硬化引起的管腔狭窄。由于CCTA软件和技术的进步,可以准确地评估冠状动脉斑块的组成和形态。将斑块识别为高风险或“易损”的不良特征可以在狭窄严重程度之上提供个性化的心血管风险评估。CCTA上的高危斑块特征包括点状钙化、低衰减斑块、正性重构和餐巾环征。然而,在CCTA上准确表征高危斑块可能具有挑战性,因此,需要教育和经验。在这篇图片文章中,提供了CCTA高危斑块特征的全面视觉指南,并提供了清晰的例子和具有挑战性的案例,突出了常见的陷阱。对于专业读者来说,重要的是要正确识别这些特征,因为它们与不良后果和潜在的未来对强化目标导向医学治疗的影响有关。
{"title":"Characterising high-risk plaque on cardiac CT.","authors":"Abdul Rahman Ihdayhid, Amro Sehly, Nick S R Lan, Nadia Denston, Benjamin J W Chow, David E Newby, Michelle C Williams, Girish Dwivedi","doi":"10.1111/1754-9485.13817","DOIUrl":"10.1111/1754-9485.13817","url":null,"abstract":"<p><p>Coronary computed tomography angiography (CCTA) is a well-established and reliable non-invasive imaging modality that provides a comprehensive assessment of coronary artery anatomy and luminal stenosis due to atherosclerosis. Owing to advances in CCTA software and technology, the composition and morphology of coronary plaque can be accurately evaluated. Adverse features which identify plaque as being high-risk or 'vulnerable' can provide a personalised cardiovascular risk assessment over and above stenosis severity. High-risk plaque features on CCTA include spotty calcification, low attenuation plaque, positive remodelling and the napkin ring sign. However, it can be challenging to characterise high-risk plaque accurately on CCTA, and as such, education and experience are required. In this pictorial essay, a comprehensive visual guide to high-risk plaque features on CCTA is provided, with clear examples and challenging cases that highlight common pitfalls. It is important for expert readers to properly identify these features given their association with adverse outcomes and potential future implications on intensive goal-directed medical therapy.</p>","PeriodicalId":16218,"journal":{"name":"Journal of Medical Imaging and Radiation Oncology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142818339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pulmonary veno-occlusive disease: A systematic review of risk factors, clinical presentation, diagnostic investigations, treatment outcomes and prognostic factors. 肺静脉闭塞性疾病:危险因素、临床表现、诊断调查、治疗结果和预后因素的系统综述。
IF 2.2 4区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-12-11 DOI: 10.1111/1754-9485.13814
Louisa P Thong, Benyamin Hakak-Zargar, Andrew T Burns, George N Harisis, Samantha J Ellis, Francis J Ha

Pulmonary veno-occlusive disease (PVOD) is a rare cause of pulmonary hypertension. We aimed to systematically evaluate published cases of PVOD to provide an overview of their clinical presentation, management and prognosis to assist early identification and treatment. We conducted a literature search of PubMed and Embase databases for adult cases of 'pulmonary veno-occlusive disease' and 'pulmonary capillary haemangiomatosis'. Data collected included baseline demographics, medical history, clinical presentation, investigations performed, treatment and outcome. Kaplan-Meier survival analysis was used for overall survival with Cox-hazards-regression model used to evaluate treatment outcomes and prognostic factors. A total of 257 cases of PVOD from 113 articles were included in our analysis (mean age 45 ± 17 years, 54% females). Most frequent associations were smoking (28%), systemic sclerosis (10%) and mitomycin exposure (9%). Cardinal CT chest findings included ground glass opacities (75%), interlobular septal thickening (74%) and lymphadenopathy (51%); however, all three features were only seen in 23% (35/151). Median overall survival was 12 months (interquartile range, 3-48 months). Lung transplantation was the only treatment associated with improved survival (P = 0.006). Right ventricular dilatation (P = 0.005), increased mean pulmonary artery pressure (P = 0.01) and reduced 6-minute walk distance (P = 0.04) were associated with poorer overall survival. This systematic review provides a clinically relevant overview of a rare and often fatal condition. There is need for early diagnosis and referral for consideration of lung transplantation, while recognising right ventricular dilatation and elevated pulmonary pressures portend poorer prognosis. PROSPERO international register CRD42024553829.

摘要肺动脉静脉闭塞性疾病(PVOD)是肺动脉高压的罕见病因。我们旨在系统地评估已发表的PVOD病例,以提供其临床表现,管理和预后的概述,以帮助早期识别和治疗。我们在PubMed和Embase数据库中检索了“肺静脉闭塞性疾病”和“肺毛细血管瘤病”的成人病例。收集的数据包括基线人口统计、病史、临床表现、进行的调查、治疗和结果。总生存率采用Kaplan-Meier生存分析,cox -hazard -regression模型评价治疗结果和预后因素。本文共纳入113篇文献中的257例PVOD病例(平均年龄45±17岁,女性占54%)。最常见的关联是吸烟(28%)、系统性硬化症(10%)和丝裂霉素暴露(9%)。胸部枢机CT表现包括磨玻璃影(75%)、小叶间隔增厚(74%)和淋巴结病变(51%);然而,这三个特征仅在23%(35/151)中出现。中位总生存期为12个月(四分位数间距为3-48个月)。肺移植是唯一与生存率提高相关的治疗方法(P = 0.006)。右心室扩张(P = 0.005)、平均肺动脉压升高(P = 0.01)和6分钟步行距离缩短(P = 0.04)与总生存期较差相关。本系统综述提供了一种罕见且经常致命的疾病的临床相关概述。有必要早期诊断和转诊考虑肺移植,而认识到右室扩张和肺动脉压升高预示着预后较差。普洛斯彼罗国际注册号CRD42024553829。
{"title":"Pulmonary veno-occlusive disease: A systematic review of risk factors, clinical presentation, diagnostic investigations, treatment outcomes and prognostic factors.","authors":"Louisa P Thong, Benyamin Hakak-Zargar, Andrew T Burns, George N Harisis, Samantha J Ellis, Francis J Ha","doi":"10.1111/1754-9485.13814","DOIUrl":"https://doi.org/10.1111/1754-9485.13814","url":null,"abstract":"<p><p>Pulmonary veno-occlusive disease (PVOD) is a rare cause of pulmonary hypertension. We aimed to systematically evaluate published cases of PVOD to provide an overview of their clinical presentation, management and prognosis to assist early identification and treatment. We conducted a literature search of PubMed and Embase databases for adult cases of 'pulmonary veno-occlusive disease' and 'pulmonary capillary haemangiomatosis'. Data collected included baseline demographics, medical history, clinical presentation, investigations performed, treatment and outcome. Kaplan-Meier survival analysis was used for overall survival with Cox-hazards-regression model used to evaluate treatment outcomes and prognostic factors. A total of 257 cases of PVOD from 113 articles were included in our analysis (mean age 45 ± 17 years, 54% females). Most frequent associations were smoking (28%), systemic sclerosis (10%) and mitomycin exposure (9%). Cardinal CT chest findings included ground glass opacities (75%), interlobular septal thickening (74%) and lymphadenopathy (51%); however, all three features were only seen in 23% (35/151). Median overall survival was 12 months (interquartile range, 3-48 months). Lung transplantation was the only treatment associated with improved survival (P = 0.006). Right ventricular dilatation (P = 0.005), increased mean pulmonary artery pressure (P = 0.01) and reduced 6-minute walk distance (P = 0.04) were associated with poorer overall survival. This systematic review provides a clinically relevant overview of a rare and often fatal condition. There is need for early diagnosis and referral for consideration of lung transplantation, while recognising right ventricular dilatation and elevated pulmonary pressures portend poorer prognosis. PROSPERO international register CRD42024553829.</p>","PeriodicalId":16218,"journal":{"name":"Journal of Medical Imaging and Radiation Oncology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142813612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Imperative for a health-centred focus on climate change in radiology. 放射学必须以健康为中心,关注气候变化。
IF 2.2 4区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-12-11 DOI: 10.1111/1754-9485.13813
Omar Taboun, Chloe DesRoche, Kate Hanneman

Climate change negatively impacts individual and population-level health through multiple pathways, including poor air quality, extreme heat and changes in infectious disease. These health effects will lead to higher health system and medical imaging utilisation. At the same time, the delivery of radiology services generates substantial greenhouse gas emissions. Mitigation strategies to reduce the environmental impact of medical imaging and adaptation strategies to build resiliency to current and future impacts of climate change in radiology should be centred on human health. A health-centred response in radiology reinforces the role of radiologists as physicians and emphasises the opportunity for medical imaging to promote health and advance our understanding of climate-related health effects. This review discusses the need for a health-centred focus on climate change in radiology, including the effects of climate change on human health and health systems, intersection of climate change with health equity, health benefits of climate action and opportunities to leverage medical imaging to improve human health.

气候变化通过多种途径对个人和人群的健康产生负面影响,包括空气质量差、极端高温和传染病的变化。这些健康影响将导致更高的卫生系统和医学成像利用率。与此同时,提供放射服务会产生大量的温室气体排放。减少医学成像对环境影响的缓解战略,以及在放射学领域建立抵御当前和未来气候变化影响的适应战略,都应以人类健康为中心。放射学以健康为中心的应对措施加强了放射科医生作为医生的作用,并强调了医学成像促进健康和增进我们对气候相关健康影响的理解的机会。本综述讨论了在放射学中以健康为中心关注气候变化的必要性,包括气候变化对人类健康和卫生系统的影响、气候变化与卫生公平的交集、气候行动的健康效益以及利用医学成像改善人类健康的机会。
{"title":"Imperative for a health-centred focus on climate change in radiology.","authors":"Omar Taboun, Chloe DesRoche, Kate Hanneman","doi":"10.1111/1754-9485.13813","DOIUrl":"https://doi.org/10.1111/1754-9485.13813","url":null,"abstract":"<p><p>Climate change negatively impacts individual and population-level health through multiple pathways, including poor air quality, extreme heat and changes in infectious disease. These health effects will lead to higher health system and medical imaging utilisation. At the same time, the delivery of radiology services generates substantial greenhouse gas emissions. Mitigation strategies to reduce the environmental impact of medical imaging and adaptation strategies to build resiliency to current and future impacts of climate change in radiology should be centred on human health. A health-centred response in radiology reinforces the role of radiologists as physicians and emphasises the opportunity for medical imaging to promote health and advance our understanding of climate-related health effects. This review discusses the need for a health-centred focus on climate change in radiology, including the effects of climate change on human health and health systems, intersection of climate change with health equity, health benefits of climate action and opportunities to leverage medical imaging to improve human health.</p>","PeriodicalId":16218,"journal":{"name":"Journal of Medical Imaging and Radiation Oncology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142813611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The sustainability impacts of a web-based outpatient booking application. 基于网络的门诊预约应用程序对可持续性的影响。
IF 2.2 4区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-11-27 DOI: 10.1111/1754-9485.13815
Melissa Yeo, Kane Nicholls, Pey Ling Shum, Hamed Asadi, Natalie Yang

Background: Climate change is a critical global issue, impacting ecosystems, economies and communities worldwide. The shift from paper-based to digital systems is becoming increasingly prevalent across industries, with downstream positive impacts on sustainability. In 2020, Austin Health, a public tertiary hospital in Victoria, Australia, adopted a web-based outpatient booking application, which succeeded the prior paper-based system. The application served as an integrated platform for administrative staff to access various Austin Information Technology platforms and replaced previous mail-based outpatient appointment notifications with Short Message Service-based notifications. This study aimed to assess the environmental impact and organisation-wide economic cost of a web-based outpatient booking application compared to the prior paper-based system across the same time period.

Methods: A retrospective environmental and economic assessment was conducted for both the web-based booking application and the paper-based system. The evaluation covered 36,925 outpatient diagnostic imaging studies - including CT, MRI, ultrasound and mammography - performed at Austin Health from 1st July 2023 until 30th June 2024. The environmental impact was assessed by calculating the expected carbon dioxide equivalent (CO2e) emissions produced by each system. The economic cost analysis was conducted from the perspective of the hospital and included the direct costs of labour and materials/consumables.

Results: CO2e emissions were significantly reduced using the web-based outpatient booking application compared to the prior paper-based system (38.5 tonnes compared to 0.002 tonnes), predominantly attributable to the elimination of postage-related fuel emissions (27.7 tonnes). The estimated net operating cost savings across the year was at least AUD 175,000 (in 2024 Australian Dollars, adjusted for inflation). This was primarily due to labour savings from the elimination of workflow inefficiencies (at least 2342 h saved) amounting to at least AUD 85,272 in salary, followed by savings from eliminated pathology tests (AUD 57,422) and postage costs (AUD 55,193).

Conclusion: The adoption of the web-based outpatient booking application led to a substantial reduction in carbon emissions and operating costs, alongside enhanced operational efficiency and productivity. These benefits are anticipated to be enduring, especially in the face of an ever-increasing demand for medical imaging services.

背景:气候变化是一个重要的全球性问题,影响着世界各地的生态系统、经济和社区。从纸质系统到数字系统的转变在各行各业越来越普遍,并对可持续发展产生了积极的下游影响。2020 年,澳大利亚维多利亚州的一家公立三级医院 Austin Health 采用了基于网络的门诊预约应用程序,取代了之前的纸质系统。该应用程序为行政人员访问奥斯汀信息技术平台提供了一个集成平台,并以基于短信服务的通知取代了之前基于邮件的门诊预约通知。本研究旨在评估与之前的纸质系统相比,基于网络的门诊预约应用程序在同一时期内对环境的影响和整个组织的经济成本:对网络预约应用程序和纸质系统进行了回顾性环境和经济评估。评估涵盖了奥斯汀健康中心自 2023 年 7 月 1 日至 2024 年 6 月 30 日期间进行的 36,925 次门诊诊断成像检查,包括 CT、核磁共振成像、超声波和乳腺 X 光检查。环境影响是通过计算每个系统产生的预期二氧化碳当量 (CO2e) 排放量来评估的。经济成本分析从医院的角度进行,包括劳动力和材料/消耗品的直接成本:结果:与之前的纸质系统相比,使用网络门诊预约应用程序大大减少了 CO2e 排放量(38.5 吨比 0.002 吨),主要原因是减少了与邮寄相关的燃料排放(27.7 吨)。据估计,全年节省的运营成本净额至少为 17.5 万澳元(按 2024 年澳元计算,并根据通胀率进行了调整)。这主要是由于消除了工作流程中的低效环节,节省了劳动力(至少节省了 2342 个小时),至少节省了 85,272 澳元的工资,其次还节省了病理化验费用(57,422 澳元)和邮寄费用(55,193 澳元):结论:采用网络门诊预约应用程序后,碳排放量和运营成本大幅降低,同时还提高了运营效率和生产率。预计这些效益将持续下去,尤其是在医疗成像服务需求不断增长的情况下。
{"title":"The sustainability impacts of a web-based outpatient booking application.","authors":"Melissa Yeo, Kane Nicholls, Pey Ling Shum, Hamed Asadi, Natalie Yang","doi":"10.1111/1754-9485.13815","DOIUrl":"https://doi.org/10.1111/1754-9485.13815","url":null,"abstract":"<p><strong>Background: </strong>Climate change is a critical global issue, impacting ecosystems, economies and communities worldwide. The shift from paper-based to digital systems is becoming increasingly prevalent across industries, with downstream positive impacts on sustainability. In 2020, Austin Health, a public tertiary hospital in Victoria, Australia, adopted a web-based outpatient booking application, which succeeded the prior paper-based system. The application served as an integrated platform for administrative staff to access various Austin Information Technology platforms and replaced previous mail-based outpatient appointment notifications with Short Message Service-based notifications. This study aimed to assess the environmental impact and organisation-wide economic cost of a web-based outpatient booking application compared to the prior paper-based system across the same time period.</p><p><strong>Methods: </strong>A retrospective environmental and economic assessment was conducted for both the web-based booking application and the paper-based system. The evaluation covered 36,925 outpatient diagnostic imaging studies - including CT, MRI, ultrasound and mammography - performed at Austin Health from 1st July 2023 until 30th June 2024. The environmental impact was assessed by calculating the expected carbon dioxide equivalent (CO<sub>2</sub>e) emissions produced by each system. The economic cost analysis was conducted from the perspective of the hospital and included the direct costs of labour and materials/consumables.</p><p><strong>Results: </strong>CO<sub>2</sub>e emissions were significantly reduced using the web-based outpatient booking application compared to the prior paper-based system (38.5 tonnes compared to 0.002 tonnes), predominantly attributable to the elimination of postage-related fuel emissions (27.7 tonnes). The estimated net operating cost savings across the year was at least AUD 175,000 (in 2024 Australian Dollars, adjusted for inflation). This was primarily due to labour savings from the elimination of workflow inefficiencies (at least 2342 h saved) amounting to at least AUD 85,272 in salary, followed by savings from eliminated pathology tests (AUD 57,422) and postage costs (AUD 55,193).</p><p><strong>Conclusion: </strong>The adoption of the web-based outpatient booking application led to a substantial reduction in carbon emissions and operating costs, alongside enhanced operational efficiency and productivity. These benefits are anticipated to be enduring, especially in the face of an ever-increasing demand for medical imaging services.</p>","PeriodicalId":16218,"journal":{"name":"Journal of Medical Imaging and Radiation Oncology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142729676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Medical Imaging and Radiation Oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1